Committee narrows collaborative pharmacy practice by excluding complex cardiac conditions from pharmacist protocols
SB 294 would bar the Board of Pharmacy from adding certain complex cardiac conditions (heart failure, coronary heart disease, cardiac rhythm disorders) to the list of conditions eligible for collaborative pharmacy practice agreements; committee members and medical groups supported the restriction.
The full story
Senator Harrell presented Senate Bill 294 to the Senate Committee on Health Policy, saying the legislation would prevent the Board of Pharmacy from adding “heart failure, coronary heart disease, [and] cardiac rhythm disorders” to the list of chronic conditions eligible for collaborative pharmacy practice agreements (CPPA).
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in